We have in recent studies (1-3) described the ability of tin-protoporphyrin to act as a potent competitive inhibitor of heme oxygenase, the rate limiting enzyme of heine degradation, both in vitro and in vivo. This synthetic metalloporphyrin, administered to newborn rats, can block the major increases in heine oxygenase activity that occur in various tissues after birth and can completely prevent the development of the hyperbilirubinemia that normally occurs postnatally.
kg bw) prepared as described above, but in a final volume of 0.1 ml. Control neonates received an equivalent volume of saline at birth. The neonates remained with their mothers throughout the experiment; groups of neonates (6-30 animals per group) were killed at the times indicated in the figures; assays were performed for serum bilirubin and heme oxygenase as described below.
Preparation of Microsomesfrom Human Spleen. Samples of human spleen, obtained during the course of operative procedures requiring spleen removal, were provided to us through the Tissue Procurement Service at the Memorial Sloan-Kettering Cancer Center, New York. The tissue was washed thoroughly with 0.9% saline to remove excess blood and then minced, homogenized in 3 vol of 0.1 M potassium phosphate buffer pH 7.4, containing 0.25 M sucrose, and the microsomal fraction was prepared as described previously (4) .
Enzyme Assays. Heme oxygenase was assayed as described (1) , and bilirubin formation was calculated on the basis of an extinction coefficient of 40 mM -1 cm -1 and the difference in absorbance between 464 nm and 530 nm. Heine oxygenase activity was expressed as nanomoles bilirubin formed per milligrams microsomal protein per h. All assays were performed in duplicate on an Aminco Chance DW2A spectrophotometer in the split-beam mode.
Total bilirubin was estimated fluorometrically by the method of Roth (5); the variation in replicate serum samples was <5%. Cr-protoporphyrin did not interfere with bilirubin deterruination in this assay. Protein concentration was determined using crystalline serum bovine albumin as standard by the method of Lowry et al. (6) . The data were analyzed by the standard t test and the value P < 0.05 was regarded as significant.
Results
The Dose-dependent Effect of Cr-Protoporphyrin on Heine Oxygenase Activity in Liver. Crprotoporphyrin administered in doses ranging from 0.5 to 50 #mol/kg bw was examined in adult male rats for its effects in vivo on heme oxygenase, the rate limiting enzyme (7, 8) of heine degradation (Table I) . Hepatic heine oxygenase activity, measured 16 h after Cr-protoporphyrin administration, was lowered in a dosedependent manner. Even at the lowest dose of the metalloporphyrin studied (0.5 #mol/kg bw), heine oxygenase activity was diminished by >50%. Splenic and renal heine oxygenase activities were also lowered in a dose-dependent manner; however, at the lowest dose of Cr-protoporphyrin examined (0.5 #mol/kg bw), no significant decrease in enzyme activity was detected in either organ (results not shown). This effect of Cr-protoporphyrin on enzyme activity was long lasting. A single administration of the metalloporphyrin at a dose of 1/~mol/kg bw resulted in a rapid (within 5 h) lowering of hepatic heme oxygenase activity to a level, by 8 h, <50% of the initial control level (1.16 + 0.13 and 2.56 + 0.22, respectively) where it remained for the succeeding 14 d.
Competitive Inhibition of Heine Oxygenase Activity
In Vitro by Cr-Protoporphyrin. The apparent Km for heine in the rat spleen microsomal heme oxygenase system was determined to be 7.68 #M, which is within the range reported previously (9, 10) . The addition of Cr-protoporphyrin (0.025 #M) to splenic heme oxygenase resulted in a marked competitive inhibition of enzyme activity, with a greater than threefold increase (7.68-25.64 #M [ Fig. 1 ]) in the apparent Km for heme. The Ki (inhibition constant) for Cr-protoporphyrin was determined to be 0.011 /.tM. This value is identical to the Ki value reported previously for tin (Sn-) protoporphyrin (1) .
On the basis of these findings (Table I , Fig. 1 ) Cr-protoporphyrin was administered to neonatal rats at birth to determine if this metalloporphyrin was capable of blocking the development of hyperbilirubinemia in the postnatal period. The dose of Crprotoporphyrin chosen (10 #mol/kg bw), to be administered in a single dose at birth to neonatal rats, was sufficient to block splenic as well as hepatic and renal heme oxygenase activity in adult animals. Effects of Cr-Protoporphyrin on Heine Oxygenase Activity and Serum Bilirubin Levels in the Neonate. The effect of a single dose (10 ~mol/kg) of Cr-protoporphyrin administered at birth on hepatic and spleen heme oxygenase activities is shown in Fig. 2 . This enzyme activity rose rapidly in liver after birth, as expected, reaching a level fourfold above normal adult levels at 5 d before commencing to decline to adult levels. In neonates receiving Cr-protoporphyrin, this liver enzyme activity declined promptly, where it remained at levels well below normal adult levels throughout the 14-d period of study. This dose of Cr-protoporphyrin also immediately and profoundly lowered (~80%) renal heine oxygenase activity, to a point where it remained throughout the entire period of study (results not shown). Splenic heme oxygenase activity in untreated neonates followed the normal course of postnatal development, being low at birth and increasing rapidly in the postnatal period to reach normal adult levels by day 14 (Fig. 2) . Administration of Cr-protoporphyrin (10 ~mol/kg bw) prevented this increase; indeed the splenic heine oxygenase activity declined markedly until day 5, when it began to increase towards the levels characteristic of the normal adult animal.
DRUMMOND AND KAPPAS BRIEF DEFINITIVE REPORT
The total bilirubin concentration in the serum of untreated neonates increased after birth, as expected, to a maximum at day 2, before commencing to decline towards the range typical of the normal adult animal (Fig. 3) . Administration of Cr-protoporphyrin (10/xmol/kg bw) at birth prevented the increase in serum bilirubin at day 2; thereafter serum bilirubin levels remained lower than those in the control group for the initial 14 d after birth. The same dose of Sn-protoporphyrin was shown earlier (3) to prevent the prompt postnatal rise of serum bilirubin levels in the newborn rat. At the dose studied (10/xmol/kg bw), Cr-protoporphyrin produced no detrimental effects in the newborn animals.
Competitive Inhibition of Heme Oxidation in Human Spleen Microsomes by Synthetic Metalloporphyrins.
The apparent Km for heine in the human spleen microsomal heme oxygenase system was determined to be 19.04 ± 0.08 #M, which is within the range reported previously for this tissue (11) . Using both Dixon and Lineweaver-Burk plots, the Ki for each of five synthetic metalloporphyrins in this system was determined; the values for Cr-and Sn-protoporphyrins indicate that these compounds were significantly more potent as competitive inhibitors of heme oxidation in human spleen than manganese, cobalt, or zinc protoporphyrins (Table II) .
Discussion
This study demonstrates that Cr-protoporphyrin, when administered to rats in single, small doses immediately after birth, can markedly inhibit the major increases that develop in the heme oxygenase activities of various tissues and can also prevent the hyperbilirubinemia that normally occurs postnatally. Cr-protoporphyrin is a powerful competitive inhibitor of heine oxygenase activity in vitro (Fig. 3 , Table II ). The Ki (0.011/.tM) of Cr-protoporphyrin for rat spleen microsomal heine oxygenase is identical to that previously reported for Sn-protoporphyrin (1). The rapidity with which heine oxygenase activity is lowered in vivo after Cr-protoporphyrin administration is undoubtedly attributable to the marked ability of this metalloporphyrin to competitively inhibit heine degradation; this effect cannot be due to inhibition of enzyme synthesis as the half-life of heine oxygenase has been previously reported to be ~16 h (12, 13) . Cr-protoporphyrin inhibition of heine oxygenase in the rat spleen microsomal system is competitive in nature (Fig. 1) , with an affinity of the metalloporphyrin for the enzyme identical to that previously determined for Sn-protoporphyrin. Both compounds also competitively inhibit the rate of heine oxidation in the human spleen microsomal heine oxygenase system to a comparable degree (Table II) . The marked affinities of these metalloporphyrins for human spleen heine oxygenase, as reflected in the Ki values (Table II) , greatly exceeded those of several other metalloporphyrins examined and was consistent with their ability to not only inhibit heine oxygenase activities in various animal tissues in vivo and in vitro, but also to concurrently suppress the hyperbilirubinemia which normally occurs in the immediate postnatal period (1, 2). As we noted earlier (1), the ability of a synthetic metalloporphyrin to inhibit heme oxygenase (1-3, 10, 14, 15) does not of itself guarantee that the compound in question will have the requisite biological characteristics in vivo to suppress hyperbilirubinemia. Whole animal studies are essential to establish this point because of the physiological and pharmacokinetic variables involved in such a response. The ineffectiveness of Mn-or Zn-protoporphyrin in preventing neonatal hyperbilirubinemia (1, 3) and the dual properties (16) of Co-protoporphyrin of inhibiting heme oxygenase in vitro while potently inducing the enzyme in vivo affirm this view.
The possibility of suppressing neonatal jaundice by appropriately regulating the rate of heine oxidation in vivo was proposed in a previous study from this laboratory (17) . Our recent studies with Sn-protoporphyrin (1, 2) have shown that this compound can effectively exert such a regulatory action in the rat neonate. Cr-protoporphyrin, as the data in the present report indicate, exerts a similar regulatory action.
Summary
The synthetic metalloporphyrin, Cr-protoporphyrin, is a potent competitive inhib-itor of heme oxygenase activity in rat spleen, liver, and kidney. When administered to neonatal animals in a single dose immediately after birth, Cr-protoporphyrin suppresses postnatal hyperbilirubinemia and produces a marked and sustained lowering of heme oxidation activity in liver, spleen, and kidney. The metalloporphyrin also potently inhibited the rate of heine degradation to bile pigment in human spleen.
